TrademarkDir
NEOMAB BIO
LIVE

Serial Number

98394125

Owner

GemPharmatech Co., Ltd.

Attorney

Nazly Aileen Bayramoglu

Filing Date

Feb 6, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEOMAB BIO Trademark

Serial Number: 98394125 • Registration: 7896288

NEOMAB BIO is a trademark filed by GemPharmatech Co., Ltd. on February 6, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GemPharmatech Co., Ltd. (13 trademarks)

12 Xuefu Road,

Entity Type: 99

Trademark Details

Filing Date

February 6, 2024

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2025 CRFA
ASSIGNED TO LIE
May 1, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 17, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 4, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 4, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 4, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 4, 2024 NWOS
NEW APPLICATION ENTERED
Feb 6, 2024 NWAP

Related Trademarks

More from this Owner

NEOMAB-HC

NEOMAB-HC

NEOMAB-HC

NEOMAB-HC

NEOMAB-HC

NEOMAB-HC

NEOMAB-CLC

NEOMAB-CLC

NEOMAB-CLC

NEOMAB-CLC

NEOMAB-CLC

NEOMAB-CLC